MicroBiopharm Japan
Tokyo, Japan
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: MicroBiopharm Japan
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Tokyo, Japan
- Website
- https://www.microbiopharm.com/en/business/manufacture.html
- Modalities
- Microbial Fermentation, High-Potency APIs, Biologics
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About MicroBiopharm Japan
MicroBiopharm Japan makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Microbial Fermentation, High-Potency APIs, Biologics. 2 manufacturing sites registered with the U.S. FDA. Website: https://www.microbiopharm.com/en/business/manufacture.html
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
MicroBiopharm Japan FDA Inspection History
2026-02
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2026-02-13 |
MicroBiopharm Japan Co., Ltd.
Iwata
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data. This company's careers site asks automated readers not to collect it (robots.txt), and we respect that.
Source:
public careers pages
· Checked Oct 30, 2026
Frequently Asked Questions About MicroBiopharm Japan
How many FDA inspections does MicroBiopharm Japan have on record?
CDMO Signal tracks 1 FDA inspection for MicroBiopharm Japan, sourced from the FDA inspection database. See the full inspection history above.
Has MicroBiopharm Japan received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for MicroBiopharm Japan.
Does MicroBiopharm Japan have a CDMO Signal Score?
Not yet. MicroBiopharm Japan is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating MicroBiopharm Japan for a manufacturing program?
Use the free AI matchmaker to compare MicroBiopharm Japan against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Nippon Kayaku
Takasaki, Gunma, Japan
High-Potency APIs, Cytotoxics, Small Molecule API, Microbial Fermentation
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 84.8
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
Richter BioLogics
Hamburg, Germany
Signal Score: 82.9
Plasmid DNA, Recombinant Proteins, VHH/Nanobodies, Bacterial Vaccines, Biologics, Microbial Fermentation
Cytovance Biologics
Oklahoma City, OK
Signal Score: 78.6
Microbial Fermentation, Biologics, Recombinant Proteins, Mammalian Cell Culture, Plasmid DNA
AbbVie Contract Manufacturing
North Chicago, Illinois, United States
Small Molecule API, High-Potency APIs, Biologics, ADC / Bioconjugation, Sterile Fill-Finish, Lyophilization, Prefilled Syringes, Oral Solid Dose, Hot-Melt Extrusion, Oral Liquids, Topicals
Compare MicroBiopharm Japan with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.